Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development
Go back to Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development| (NASDAQ: OVID) | Delayed: 2.40 +0.02 (0.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.38 | 52 Week High | $ | |||
| Open | $2.36 | 52 Week Low | $ | |||
| Day High | $2.43 | P/E | N/A | |||
| Day Low | $2.29 | EPS | $ | |||
| Volume | 4,728,434 | |||||

